Cite
MLA Citation
Rishi Gupta et al.. “An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic.” Rheumatology, vol. 60, 2021, pp. 977–979. http://access.bl.uk/ark:/81055/vdc_100121988019.0x00003d